Targeting Bortezomib to Bone Increases Its Bone Anabolic Activity and Reduces Systemic Adverse Effects in Mice
2019 ◽
Vol 35
(2)
◽
pp. 343-356
◽
1980 ◽
Vol 38
◽
pp. 112-113
2003 ◽
Vol 3
(2)
◽
pp. 293-309
2018 ◽
Vol 32
(4)
◽
pp. 182-190
◽
Keyword(s):
Keyword(s):
Keyword(s):